|
|
Hematopathology Subdivision Report
 |
By
Kojo S. J. Elenitoba-Johnson, MD
Chair, Hematopathology Subdivision
e-mail: kojoelen@umich.edu |
Tim
Greiner
and I have planned an exciting Hematopathology program for
the 2009 AMP Annual Meeting. The program will be kicked off
with Bryan Betz who will be speaking on mutations
with prognostic significance in acute myelogenous leukemia
in an Early Bird Session. The program will also feature two
workshops. The first session will consist of a platform
presentation of selected abstracts featuring exciting work
that is being conducted by trainees and AMP members. The
second Workshop will feature presentations discussing
acquired mutations in myeloproliferative disorders. Joseph
Prchal will speak about somatic mutations and uniparental
disomy in
Philadelphia
chromosome negative myeloproliferative diseases. Rebecca
McClure will discuss the practical issues associated
with detection of JAK2 and other acquired mutations
in chronic myeloproliferative disorders. The Plenary Session
will address the increasingly recognized role of deregulated
NFκB signaling in the pathogenesis of malignant
lymphomas. In this session, Laura Pasqualucci will discuss
the pathway alterations in diffuse large B-cell lymphoma and
Vu Ngo will discuss discoveries enabled by the
RNA interference (RNAi) screens for identification of
molecular targets in lymphoma. The Hematopathology program
promises to be very exciting. We look forward to some very
interactive and informative sessions. |